Page last updated: 2024-09-05

dehydrodieugenol and Asthma, Bronchial

dehydrodieugenol has been researched along with Asthma, Bronchial in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Arantes-Costa, FM; Caperuto, LC; Claudio, SR; da Silva, RC; Lago, JHG; Lima-Neto, LG; Olivo, CR; Pinheiro, AJMCR; Ponci, V; Prado, CM; Ribeiro, DA; Santana, FPR; Tibério, IFLC	1

Other Studies

1 other study(ies) available for dehydrodieugenol and Asthma, Bronchial

Article	Year
Dehydrodieugenol improved lung inflammation in an asthma model by inhibiting the STAT3/SOCS3 and MAPK pathways. Biochemical pharmacology, 2020, Volume: 180 Topics: Animals; Asthma; Dose-Response Relationship, Drug; Eugenol; Lauraceae; Lignans; Male; MAP Kinase Signaling System; Mice; Mice, Inbred BALB C; Plant Extracts; Pneumonia; RAW 264.7 Cells; STAT3 Transcription Factor; Suppressor of Cytokine Signaling 3 Protein	2020

Article

Year

Dehydrodieugenol improved lung inflammation in an asthma model by inhibiting the STAT3/SOCS3 and MAPK pathways.

Biochemical pharmacology, 2020, Volume: 180

Topics: Animals; Asthma; Dose-Response Relationship, Drug; Eugenol; Lauraceae; Lignans; Male; MAP Kinase Signaling System; Mice; Mice, Inbred BALB C; Plant Extracts; Pneumonia; RAW 264.7 Cells; STAT3 Transcription Factor; Suppressor of Cytokine Signaling 3 Protein

2020